CXCL9 and CXCL10 levels were significantly higher in patients (active and stable groups) than controls, and among the vitiligo patients, CXCL9 and CXCL10 levels were significantly higher in active than stable groups. The gene discussed is CXCL9; the disease is vitiligo.